RE: MyProtein UK competitors1 Nov 2022 06:09
Good debate yesterday evening Folks
Helicopter view consensus ?
- EBITA valuation maybe the markets choice way to value
THG eventually ?
- We range from 10X to 14X EBITA which appears to be the market value for our sector on LSE
Important because IF we do hit £100M EBITA this year we
should be valued at £1.4B £1 a share before looking forward
IF guidance is £160M EBITA 2023 it gives us some idea of where the share price could be if Moulding / The Good Lord change tact with their communication
So Mouldy may well be in tricky position? If we can form a consensus range on value so can the larger II investors
they will be saying similar to us little PI’s sharing data on a BB
He’s not going to be able to go lower than £1.20 on £100M EBITA 2022 baking in that market value should be on 2023 £EBITA
On forward £160M 2023 EBITA at X14 EBITA we have £1.60
£1.20 to £1.60 range he is looking at, he has to be, funded by Qatar, if he doesn’t pull it off we get to the £1.20 / £1.60’2023 by default as the £160M EBITA comes through and his Golden Share expires
Put aside cost savings / Ingenuity growing and other side of the debate, competition, World economy, I would take the
£100M EBITA today for 2022 and the £160M EBITA for 2023
we know what the market value of our shares will / should be
Nb the II shorts can see these numbers as well